Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 4
2016 4
2017 2
2018 6
2020 2
2021 4
2022 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.
de Gooyer PGM, Verschoor YL, van den Dungen LDW, Balduzzi S, Marsman HA, Geukes Foppen MH, Grootscholten C, Dokter S, den Hartog AG, Verbeek WHM, Woensdregt K, van den Broek JJ, Oosterling SJ, Schumacher TN, Kuhlmann KFD, Beets-Tan RGH, Haanen JBAG, van Leerdam ME, van den Berg JG, Chalabi M. de Gooyer PGM, et al. Among authors: van den broek jj. Nat Med. 2024 Nov;30(11):3284-3290. doi: 10.1038/s41591-024-03250-w. Epub 2024 Sep 15. Nat Med. 2024. PMID: 39278994 Free PMC article. Clinical Trial.
Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced?
Martens MH, van Heeswijk MM, van den Broek JJ, Rao SX, Vandecaveye V, Vliegen RA, Schreurs WH, Beets GL, Lambregts DM, Beets-Tan RG. Martens MH, et al. Among authors: van den broek jj. Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1005-14. doi: 10.1016/j.ijrobp.2015.09.008. Epub 2015 Sep 15. Int J Radiat Oncol Biol Phys. 2015. PMID: 26581139 Review.
Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
van den Broek JJ, Schechter CB, van Ravesteyn NT, Janssens ACJW, Wolfson MC, Trentham-Dietz A, Simard J, Easton DF, Mandelblatt JS, Kraft P, de Koning HJ. van den Broek JJ, et al. J Natl Cancer Inst. 2021 Apr 6;113(4):434-442. doi: 10.1093/jnci/djaa127. J Natl Cancer Inst. 2021. PMID: 32853342 Free PMC article.
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
van Ravesteyn NT, Schechter CB, Hampton JM, Alagoz O, van den Broek JJ, Kerlikowske K, Mandelblatt JS, Miglioretti DL, Sprague BL, Stout NK, de Koning HJ, Trentham-Dietz A, Tosteson ANA; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network. van Ravesteyn NT, et al. Among authors: van den broek jj. J Natl Cancer Inst. 2021 Aug 2;113(8):1017-1026. doi: 10.1093/jnci/djaa218. J Natl Cancer Inst. 2021. PMID: 33515225 Free PMC article.
25 results